Completed research + results
Making sustained progress in understanding, treating and ultimately curing leukemia requires advances across multiple areas, including cancer cell biology, causes and risk factors, treatments, and relapse prevention. Each year recipients of the Leukemia Research Foundation’s New Investigator Award contribute to those advances through their innovative research projects. Explore below the results and impact of recently completed research.
Hussein Abbas, MD, PhD
The University of Texas MD Anderson Cancer Center
Grant awarded: 2022
Disease: Leukemia (AML)
Research focus: Causes/risk factors (MDS)
Timothy Barrow, PhD
University of Essex
Grant awarded: 2022
Disease: Chronic lymphocytic leukemia (CLL)
Research focus: Relapse Prevention (minimal residual disease)
Lina Benajiba, MD, PhD
INSERM Institute of Health and Medical Research
Grant awarded: 2022
Disease: Acute myeloid leukemia (AML)
Research focus: Cancer cell biology (microenvironment)
Xufeng Chen, PhD
New York University School of Medicine
Grant awarded: 2022
Disease: Leukemia (AML)
Research focus: Treatment (immunotherapy)
Christian Hurtz, PhD
Temple University
Grant awarded: 2022
Disease: Acute lymphoblastic leukemia (ALL)
Research focus: Treatment (targeted therapy)
Jo Ishizawa, MD, PhD
The University of Texas MD Anderson Cancer Center
Grant awarded: 2022
Disease: Leukemia (AML)
Research focus: Treatment (targeted therapy)
Max Jan, MD, PhD
Massachusetts General Hospital
Grant awarded: 2022
Disease: Leukemia (CLL)
Research focus: Treatment (immunotherapy)
Yoon-A Kang, PhD
Washington University in St. Louis
Grant awarded: 2022
Disease: Leukemia (MPNs)
Research focus: Causes/risk factors (MPNs)
Anja Karlstaedt, MD, PhD
Cedars-Sinai Medical Center
Grant awarded: 2022
Disease: Leukemia (AML)
Research focus: Cancer cell biology (microenvironment)
David Kurtz, MD, PhD
Stanford University
Grant awarded: 2022
Disease: Multiple myeloma
Research focus: Treatment (immunotherapy)
Laura Mondragon Martinez, PhD
Josep Carreras Leukaemia Research Institute
Grant awarded: 2022
Disease: Lymphoma (non-Hodgkin)
Research focus: Treatment (immunotherapy)
Rui Su, PhD
Beckman Research Institute of the City of Hope
Grant awarded: 2022
Disease: Acute myeloid leukemia (AML)
Research focus: Cancer cell biology (leukemia stem cells)
Terrence Wong, MD, PhD
University of Michigan
Grant awarded: 2022
Disease: Leukemia (AML)
Research focus: Causes/risk factors (genetics)
Emanuele Azzoni, PhD
University of Milano-Bicocca
Grant awarded: 2021
Disease: Leukemia (JMML)
Research focus: Cancer cell biology (leukemia stem cells)
George Burslem, PhD
University of Pennsylvania
Grant awarded: 2021
Disease: Leukemia (AML, ALL)
Research focus: Causes/risk factors (epigenetics)
Matt Christopher, MD, PhD
Washington University, St.Louis
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Relapse prevention (maintenance therapy)
Leslie Crews, PhD
University of California, San Diego
Grant awarded: 2021
Disease: Multiple myeloma
Research focus: Cancer cell biology (cancer stem cells)
Ernesto Diaz-Flores, PhD
University of California, San Francisco
Grant awarded: 2021
Disease: Leukemia (ALL)
Research focus: Treatment (targeted therapy)
Cihangir Duy, MS, PhD
Fox Chase Cancer Center
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Cancer cell biology (leukemia cell biology)
Ann-Kathrin Eisfeld, MD
The Ohio State University
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Causes/risk factors (genetics)
Pietro Genovese, PhD
Dana-Farber Cancer Institute
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Treatment (immunotherapy)
Md Kamrul Hasan, PhD
University of California, San Diego
Grant awarded: 2021
Disease: Leukemia (CLL)
Research focus: Cancer cell biology (microenvironment)
Sangmoo Jeong, PhD
Johns Hopkins University
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Cancer cell biology (leukemia stem cells)
Huacheng Luo, PhD
Pennsylvania State University
Grant awarded: 2021
Disease: Leukemia (AML)
Research focus: Causes/risk factors (genetics)
Mithun Shah, MD, PhD
Mayo Clinic
Grant awarded: 2021
Disease: Leukemia (MDS)
Research focus: Causes/risk factors (MDS
Alexander Valvezan, PhD
Rutgers, The State University of New Jersey
Grant awarded: 2021
Disease: Leukemia (ALL)
Research focus: Treatment (targeted therapy)
Zhiquan Wang, PhD
Mayo Clinic - Rochester, Minnesota
Grant awarded: 2021
Disease: Chronic lymphocytic leukemia (CLL)
Research focus: Causes/risk factors (epigenetics)